Epitope regulatory update

EPT (Beaverton, Ore.) said it made "good progress" in its follow-up meeting with the FDA concerning the 57 infractions the agency found in a January preapproval inspection of EPT's facilities for manufacture of its OraSure oral specimen collection device. EPT said the infractions were in the areas of quality control, quality assurance and validity. ...